Blumhouse Atomic Aims to Extend $2.5 Billion Horror Success in 2027

Blumhouse Atomic has generated more than $2.5 billion in global box office revenue since its 2024 merger. The combined company's horror slate achieved this against total production budgets of less than $330 million.

This financial efficiency was particularly sharp in 2026. Films released that year earned nearly $1.3 billion worldwide on production budgets of less than $70 million. The company's global box office revenue for both 2025 and 2026 exceeded $1 billion each year. Jason Blum reflected on the merger's outcome, stating: "When we merged our companies, we believed the whole would be greater than the sum of its parts, and that is exactly what has happened."

2027 film slate and franchise expansion

The company's 2027 strategy aims to replicate this success with a mix of original films and returning franchises. The confirmed lineup includes 'River', 'The Revenge of La Llorona', 'The Exorcist: Martyrs', 'Anything But Ghosts', 'Paranormal Activity', 'Molepeople', 'Blair Witch', 'Sleepover', and 'Seasons'.

James Wan and Jason Blum are actively developing new installments of the 'Paranormal Activity' and 'Blair Witch' franchises. A new chapter of 'Saw' is also planned, reuniting Wan with the franchise he co-created. Blumhouse Atomic acquired the prospective rights to 'Saw' in 2025.

Television and gaming expansion

Blumhouse Atomic is expanding its horror footprint beyond theaters. Its television division has series in development for multiple platforms.

The company is also pursuing partnerships in gaming, live entertainment, and consumer products. A gaming project titled 'Grave Seasons' is in the works. Live experiences include a 'Paranormal Activity' Broadway show and franchise collaborations at Universal's Halloween Horror Nights. Consumer products are available through its online store.

Creative leadership and development focus

Creative leaders James Wan and Jason Blum emphasize developing new voices in horror. Wan noted that the combined company now houses some of the genre's most recognizable properties, including 'The Conjuring' franchise, 'Insidious,' and 'Saw'.

To cultivate this talent, the company appointed Sam Zimmerman as senior vice president of development and acquisitions in 2024. His mandate is to oversee a slate of genre features with budgets under $5 million. This low-budget development arm operates alongside the larger franchise productions. The company also signed a first-look deal with Divide/Conquer in late 2025 to develop more high-concept, cost-efficient genre films.

Blumhouse and Atomic Monster continue to operate as distinct production labels within the combined entity. The company's mission focuses on supporting filmmakers and cultivating blockbuster horror hits from undersized budgets.